Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /4132
chevron_leftBack
Golden Biotechnology Corp. logo

Golden Biotechnology Corp.

4132
TPEX: 4132 Delayed
3.47TWD 0%
0.1098 USD
As of 8 June 2026, Golden Biotechnology Corp. has a market cap of $17.83M USD, ranking #37877 globally and #2260 in Taiwan. It ranks #3383 in the Healthcare sector, and #214 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
37877
Country Rank
2260
Sector Rank
3383
Industry Rank
214
Key Stats
Market Cap
$17.83MUSD
562.93M TWD
Enterprise Value
$26.26MUSD
829.73M TWD
Revenue (TTM)
$1.41MUSD
44.58M TWD
EBITDA (TTM)
-$8.87MUSD
-280.29M TWD
Net Income (TTM)
-$9.97MUSD
-314.93M TWD
PS Ratio
12.6
PB Ratio
3.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Wenjian Cai open_in_new
Founded
2002
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -14% -75% -83% -70% -72%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
4132
國鼎生物科技股份有限公司
ISIN: TW0004132006
Shares Out.:
182.227M1 Shares Float: 163.727M2
TV:
SA:
YF:
GF:
BA:
MS:
3.47 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Golden Biotechnology Corp.

Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males. The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)
Name
Market Cap diff.
PE
$1.68B
52.95B TWD
9K%
17.9
1707
$534.8M
16.89B TWD
3K%
14.0
$474.56M
14.99B TWD
3K%
36.5
8436
$413.48M
13.06B TWD
2K%
13.7
4128
$290.57M
9.18B TWD
2K%
-
7832
$243.37M
7.69B TWD
1K%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.17B
108.92B ILS
208K%
24.2
$29.56B
166K%
-
$15.84B
107.34B CNY
89K%
16.0
CIPLA
$11.16B
1.06T INR
63K%
23.4
LUPIN
$11.04B
1.05T INR
62K%
22.7
$9.09B
61.6B CNY
51K%
80.6
chevron_leftBack